1165923-89-6

Basic information

• Product Name: tert-butyl 6-hydroxy-5-methyl-3,4-dihydroisoquinoline-2(1H)-carboxylate
• Synonyms: tert-butyl 6-hydroxy-5-methyl-3,4-dihydroisoquinoline-2(1H)-carboxylate;Tert-Butyl 6-Hydroxy-5-Methyl-3,4-Dihydroisoquinoline-2(1H)-Carboxylate(WX645100)
• CAS NO: 1165923-89-6
• Molecular Formula: C₁₅H₂₁NO₃
• Molecular Weight: 263.33214
• Mol File: 1165923-89-6.mol
• Article Data: 12

Chemical Properties

• Appearance: /
• CAS DataBase Reference: tert-butyl 6-hydroxy-5-methyl-3,4-dihydroisoquinoline-2(1H)-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 6-hydroxy-5-methyl-3,4-dihydroisoquinoline-2(1H)-carboxylate(1165923-89-6)
• EPA Substance Registry System: tert-butyl 6-hydroxy-5-methyl-3,4-dihydroisoquinoline-2(1H)-carboxylate(1165923-89-6)

Safety Data

• Hazardous Substances Data: 1165923-89-6(Hazardous Substances Data)

Upstream product

• 823-96-1 Trimethylboroxine 
• 13061-96-6 dihydroxy-methyl-borane 
• 591-31-1 3-methoxy-benzaldehyde 
• 1165923-84-1 6-methoxy-5-methyl-3,4-dihydroisoquinoline-2(1H)-carbaldehyde 
• 1165923-83-0 N-(3-methoxy-2-methylphenethyl)formamide 
• 1165923-78-3 (E)-1-methoxy-2-methyl-3-(2-nitrovinyl)benzene 
• 56724-03-9 3-methoxy-2-methyl-benzaldehyde 
• 1398414-04-4 CH₂O₂*C₁₁H₁₅NO 
• 33797-35-2 2-(3-methoxy-2-methylphenyl)acetonitrile 
• 42981-94-2 1-(chloromethyl)-3-methoxy-2-methylbenzene 
• 1165923-81-8 2-(3-methoxy-2-methylphenyl)ethanamine 
• 55289-06-0 3-methoxy-2-methylbenzoic acid 
• 33797-34-1 (3-methoxy-2-methylphenyl)methanol 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 1165923-91-0 1,1-dimethylethyl 5-methyl-6-{[(trifluoromethyl)sulfonyl]oxy}-3,4-dihydro-2(1H)-isoquinolinecarboxylate 
• 1165924-06-0 1,1-dimethylethyl 6-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-5-methyl-3,4-dihydro-2(1H)-isoquinolinecarboxylate 
• 1165923-51-2 2-isopropoxy-5-(3-(5-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)-1,2,4-oxadiazol-5-yl)benzonitrile trifluoroacetate 
• 1165924-07-1 ethyl [6-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-5-methyl-3,4-dihydro-2(1H)-isoquinolinyl]acetate 
• 1165924-09-3 ethyl 3-[6-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-5-methyl-3,4-dihydro-2(1H)-isoquinolinyl]propanoate 
• 1165923-53-4 2-(6-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-5-methyl-3,4-dihydroisoquinolin-2(1H)-yl)acetic acid 
• 1165923-54-5 sodium 3-[6-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-5-methyl-3,4-dihydro-2(1H)-isoquinolinyl]propanoate 
• 1258440-14-0 3-[6-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,3,4-thiadiazol-2-yl)-5-methyl-3,4-dihydro-2(1H)-isoquinolinyl]propanoic acid sodium salt 
• 1258440-16-2 4-[6-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,3,4-thiadiazol-2-yl)-5-methyl-3,4-dihydro-2(1H)-isoquinolinyl]butanoic acid sodium salt 
• 1258440-72-0 tert-butyl 6-(5-(3-cyano-4-isopropoxyphenyl)-1,3,4-thiadiazol-2-yl)-5-methyl-3,4-dihydroisoquinoline-2(1H)-carboxylate 
• 1258440-13-9 2-[(1-methylethyl)oxy]-5-[5-(5-methyl-1,2,3,4-tetrahydro-6-isoquinolinyl)-1,3,4-thiadiazol-2-yl]benzonitrile monohydrochloride 
• 1258440-73-1 ethyl 3-[6-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,3,4-thiadiazol-2-yl)-5-methyl-3,4-dihydro-2(1H)-isoquinolinyl]propanoate 
• 1258440-74-2 ethyl 4-[6-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,3,4-thiadiazol-2-yl)-5-methyl-3,4-dihydro-2(1H)-isoquinolinyl]butanoate 
• 1258855-44-5 1,1-dimethylethyl {3-[6-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-5-methyl-3,4-dihydro-2(1H)-isoquinolinyl]-3-oxopropyl}carbamate 

Relevant articles and documents

Compounds and methods of use

Compounds are provided according to Formula (I): and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein X1, X2, X3, X4, Y, A, L1, L2, R1, R2, R5, m and n are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.

TRICYCLIC PIPERIDINE COMPOUNDS

The present invention relates to compounds of the formula (I) wherein R1a, R1b, R2, R3, (R4)n and ring (A) are as described in the description, to their preparation, to pharmaceutically acc

ALKOXY PYRAZOLES AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS

The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6 and R7 are as defined herein. The inventi